Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Anant Ramaswamy

Showing results (1-10 of 185) with videos related to

Pageof 19
Sort By:
Indian Journal of Cancer|January 3, 2022
Older patients with cancer require and deserve more!Anant Ramaswamy, Vanita Noronha
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Reply to N. Okano et alAnant Ramaswamy, Vikas Ostwal
Translational Gastroenterology and Hepatology|December 22, 2017
What drives the wheel towards long-term outcome in advanced GIST, its size, genotype or may be a pill or two of imatinib?Vikas Ostwal, Anant Ramaswamy
Chinese Clinical Oncology|April 5, 2019
A step ahead on CTHRC1, and not just reinventing the wheel!Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal
Journal of Gastrointestinal Cancer|January 21, 2020
Real-World Long-Term Outcomes with Perioperative EOX in D2 Gastrectomy: a Meaningful Look While We Switch to FLOT-4Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal
Journal of Gastrointestinal Oncology|June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experienceArvind Sahu, Anant Ramaswamy, Vikas Ostwal
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 2, 2012
Total Leukocyte Counts and the Requirement of Dose Reduction due to Cytopenias as Prognostic Indicators Affecting Response to Imatinib in Chronic Myeloid LeukemiaA K Tripathi, Ashutosh Kumar, Anant Ramaswamy
Nuclear Medicine Communications|October 12, 2018
Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this settingAshwini Kalshetty, Anant Ramaswamy, Vikas Ostwal, et al.
South Asian Journal of Cancer|September 9, 2016
Indian data on bone and soft tissue sarcomas: A summary of published study resultsAnant Ramaswamy, Bharat Rekhi, Sameer Bakhshi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 2, 2019
Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder CancerAbhay K Kattepur, Shraddha Patkar, Mahesh Goel, et al.
Pageof 19

Showing results (1-10 of 185) with videos related to

Sort By:
Pageof 19
Indian Journal of Cancer|January 3, 2022
Older patients with cancer require and deserve more!Anant Ramaswamy, Vanita Noronha
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|March 12, 2024
Reply to N. Okano et alAnant Ramaswamy, Vikas Ostwal
Translational Gastroenterology and Hepatology|December 22, 2017
What drives the wheel towards long-term outcome in advanced GIST, its size, genotype or may be a pill or two of imatinib?Vikas Ostwal, Anant Ramaswamy
Chinese Clinical Oncology|April 5, 2019
A step ahead on CTHRC1, and not just reinventing the wheel!Siddharth Turkar, Anant Ramaswamy, Vikas Ostwal
Journal of Gastrointestinal Cancer|January 21, 2020
Real-World Long-Term Outcomes with Perioperative EOX in D2 Gastrectomy: a Meaningful Look While We Switch to FLOT-4Anant Ramaswamy, Prabhat Bhargava, Vikas Ostwal
Journal of Gastrointestinal Oncology|June 11, 2016
Dihydro pyrimidine dehydrogenase deficiency in patients treated with capecitabine based regimens: a tertiary care centre experienceArvind Sahu, Anant Ramaswamy, Vikas Ostwal
Indian Journal of Hematology & Blood Transfusion : an Official Journal of Indian Society of Hematology and Blood Transfusion|March 2, 2012
Total Leukocyte Counts and the Requirement of Dose Reduction due to Cytopenias as Prognostic Indicators Affecting Response to Imatinib in Chronic Myeloid LeukemiaA K Tripathi, Ashutosh Kumar, Anant Ramaswamy
Nuclear Medicine Communications|October 12, 2018
Resistant functioning and/or progressive symptomatic metastatic gastroenteropancreatic neuroendocrine tumors: efficacy of 177Lu-DOTATATE peptide receptor radionuclide therapy in this settingAshwini Kalshetty, Anant Ramaswamy, Vikas Ostwal, et al.
South Asian Journal of Cancer|September 9, 2016
Indian data on bone and soft tissue sarcomas: A summary of published study resultsAnant Ramaswamy, Bharat Rekhi, Sameer Bakhshi, et al.
Journal of Gastrointestinal Surgery : Official Journal of the Society for Surgery of the Alimentary Tract|February 2, 2019
Role of Adjuvant Chemotherapy in Resected T2N0 Gall Bladder CancerAbhay K Kattepur, Shraddha Patkar, Mahesh Goel, et al.
Pageof 19